In this study, a total of 10 different cell lines were included in the in vitro data section, representing a full spectrum of PC phenotypes and their oncogenic attributes were examined including: androgen sensitivity, sensitivity to two chemotherapeutic agents commonly used in PC (enzalutamide and docetaxel), AR pathway gene expression, and transcriptional landscape. The gene discussed is AR; the disease is pachyonychia congenita.